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Protein Structure and Conformation II
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Protein interactions commonly involve lock-and-key associations between in-
teracting domains. Structural features of these binding partners regulate the
nature and extent of their interactions. We report our investigations on specific
physical characteristics required of the Hsp40 J-domain to stimulate ATP hy-
drolysis in the Hsp40-Hsp70 molecular chaperone machine. Characterization
of functional and dysfunctional Hsp40-Hsp70 interactions using isothermal
titration calorimetry (ITC), and nuclear magnetic resonance (NMR) spectros-
copy reveals the importance of structural rigidity for Hsp40 function. Our re-
sults suggest that the functional J-domain acts like a semi-elliptical spring,
whose resistance to bending in Hsp40-Hsp70 interactions modulates the
ATPase domain conformational change and promotes ATP hydrolysis.
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Soluble guanylate cyclase (sGC) is a ~150 kDa heterodimeric enzyme that
plays a crucial role in the cardiovascular system by catalyzing the conversion
of GTP into cGMP, a secondary messenger whose downstream effects include
vasodilation and inhibiting platelet aggregation. Using a heme prosthetic group
located at the b N-terminus, nitric oxide (NO) binds to sGC and induces a
conformational change, increasing catalytic activity several hundred-fold. Inhi-
bition of sGC activity through oxidative stress and NO-scavengers has been
linked to cardiovascular disease. Due to a lack of structural data, how sGC tran-
sitions between basal and active states remains largely unknown. The ultimate
goal in our lab is to provide a detailed structural mechanism for sGC activation
to guide structure-based drug design of novel small molecule sGC activators to
treat cardiovascular diseases.
We have recently solved the structure of the catalytic heterodimeric wild-type
abGC. Activity assay results showed that this construct only displays ~ 0.01%
of full-length sGC basal activity, suggesting that additional sGC domains are
required to align active site residues in a catalytically-competent position.
Our efforts are now focused on strategies to overcome this limitation and obtain
the structure of the active conformation of the heterodimeric catalytic domains.
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Plasminogen (Pgn) is the precursor of plasmin, a proteinase that plays key roles
in tissue remodeling, cell migration, fibrinolysis, etc. Pgn, Mr ~92 kD, is struc-
tured by seven in-tandem globular domains: an N-terminal preactivation
peptide (PAN, 77 aa), five kringle (K) repeats (~ 80 aa each), and a
trypsinogen-like serine protease zymogen (243 aa). Upon activation, Pgn un-
dergoes a conformational change such that binding sites in kringles become
accessible and able to interact with fatty acids and exposed lysyl side-chains.
Via molecular dynamics (MD) simulations, we have investigated changes in
inter-domain interactions that reflect supra-fold of Pgn. A model structure built
by connecting sequential domains with fully extended flexible linkers was
placed in a box of 282487 explicit water molecules and allowed to equilibrate
for 420 ns via NAMD under CHARMM force field. During the MD, the protein
folds as monitored by its radius of gyration (RG) that decreases from 157 A˚ to
34 A˚, in good agreement with experimental observations (Mangel WF, Lin
BH, Ramakrishnan V. Science 1990;248:69-73; Ponting CP, Holland SK,
Cederholm-Williams SA, et al. Biochim Biophys Acta 1992;1159:155-161).
The equilibrated structure is compact with a spiral spatial configurations of
the in-tandem domains, as reported for the crystal (Law RHP, Caradoc-
Davies T, Cowieson N, et al. Cell Reports 2012;1:185-190). By reversing thetime course of the trajectory, dynamics insights are gained for the unfolding
that accompanies the Pgn conformational change in the process of fibrinolysis.
The PAN-K5 interaction was analyzed via free energy calculations as a func-
tion of relevant key inter-atomic distances. Two energy minima unveil config-
urations that exhibit strong and weak interactions between the PAN Lys 50 and
the Asp516/Asp518 loci at the canonical K5 lysine binding site.
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A method is described for maximum likelihood estimation (MLE) of the rela-
tive abundances of different conformations of a protein in a heterogeneous
mixture based on small angle X-ray scattering (SAXS) intensities.
This approach is of particular interest in situations where there are unknown,
intermediate conformations, for instance, during catalytic cycling of a protein.
First, an ensemble of structures is generated using molecular dynamics, crystal-
lography or other technique. This ensemble is then clustered into sub-sets based
on k-means clustering and the Cramer-Rao bound on the mixture coefficient
estimation error. A sparse basis set that represents the space spanned by the
measured SAXS intensities of the conformations of a protein is then generated
from representative members of each cluster. Based on a statistical model for
the intensity measurements, we show that the MLE approach can be expressed
as a constrained convex optimization problem. Starting with a basis set gener-
ated from known conformations of the enzyme, adenylate kinase (ADK), we
carried out Monte Carlo simulations to assess the performance of the proposed
estimation scheme. We demonstrate the utility of the approach by identification
of dominant conformations under different solution conditions and provide es-
timates of the abundance of minor species as a function of concentration of
different ligands.
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Predicting the structure of proteins via computer simulations could be greatly
accelerated by using our general knowledge of globular proteins. For example:
globular proteins have hydrophobic cores. This kind of information provides
many possible restraints, only a few of which are true. How can we leverage
this information in simulations to accelerate folding at the same time that we
use only the small part of the information that is correct?
We have recently developed a method called MELD (modeling employing
limited data) that can deal with ambiguous and erroneous information in atom-
istic simulations allowing us to fold a set of 20 small proteins up to five orders
of magnitude faster than in brute force atomistic simulations alone. We have
recently competed in a blind test competition (CASP) which allowed to show-
case this method for proteins over 100 residues long and under strict time
constraints.
1055-Pos Board B6
Elucidating the Functional Significance of the C-Terminal Hypervariable
Region (HVR) in K-Ras4A
Mayukh Chakrabarti1,2, Shaoyong Lu3, Hyunbum Jang2,4,
Lyuba Khavrutskii2, Nadya I. Tarasova2, Vadim Gaponenko5,
Ruth Nussinov2,4.
1Department of Biotechnology, Johns Hopkins University, Baltimore, MD,
USA, 2Cancer and Inflammation Program, Frederick National Laboratory for
Cancer Research, National Cancer Institute, Frederick, MD, USA, 3Shanghai
JiaoTong University, School of Medicine, Shanghai, China, 4Basic Science
Program, Leidos Biomedical Research, Inc., Frederick National Laboratory
for Cancer Research, National Cancer Institute, Frederick, MD, USA,
5Departments of Medical Chemistry and Biochemistry & Molecular
Genetics, University of Illinois at Chicago, Chicago, IL, USA.
In humans, three ubiquitously expressed genes (HRAS, KRAS, NRAS) encode
four different isoforms of the Ras protein. Ras is a member of the guanine
nucleotide-binding protein superfamily, and acts as a ‘‘molecular switch’’ to ef-
fect diverse cellular activities, including proliferation, differentiation, and cell
survival. Oncogenic mutations equally affect the highly-expressed K-Ras4B
splice variant of KRAS, which is amongst the most frequently observed in hu-
man tumors, and the K-Ras4A splice variant, which exhibits low mRNA
expression in cells. These isoforms share a nearly identical polypeptide
